No abstract available
Keywords:
HSCT; IL-15-activated; cytokine-induced killer cells; efficacy; immunological control; relapse.
Publication types
-
Letter
-
Multicenter Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Child
-
Child, Preschool
-
Cytokine-Induced Killer Cells / cytology
-
Cytokine-Induced Killer Cells / drug effects
-
Cytokine-Induced Killer Cells / immunology
-
Cytokine-Induced Killer Cells / transplantation*
-
Female
-
Graft vs Host Disease / diagnosis
-
Graft vs Host Disease / immunology
-
Graft vs Host Disease / pathology
-
Haplotypes
-
Hematopoietic Stem Cell Transplantation*
-
Histocompatibility Testing
-
Humans
-
Infant
-
Interleukin-15 / pharmacology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
-
Leukemia, Myeloid, Acute / immunology
-
Leukemia, Myeloid, Acute / pathology
-
Leukemia, Myeloid, Acute / therapy*
-
Male
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
-
Recurrence
-
Remission Induction
-
Tissue Donors
-
Transplantation, Homologous